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Epithelial to mesenchymal transition (EMT)Notch signaling is essential for proper cardiac development. We recently identiﬁed missense variants in the
NOTCH1 receptor in patients with diverse left ventricular outﬂow tract (LVOT) malformations (NOTCH1G661S
and NOTCH1A683T) that reduce ligand-induced Notch signaling. Here, we examine the molecular
mechanisms that contribute to reduced signaling and perturbed development. We ﬁnd that NOTCH1A683T
exhibits reduced S1 cleavage due to impaired trafﬁcking through the endoplasmic reticulum (ER). This
observation is consistent with improper localization of the variant receptor to the ER and decreased
presentation at the cell surface. In contrast, the nearby mutation NOTCH1G661S exhibits reduced cell-surface
presentation in the absence of overt folding or trafﬁcking defects. To examine the implications of these
variants in disease pathogenesis, we investigated their effect on epithelial-to-mesenchymal transition (EMT),
a critical process for development of the outﬂow tract. We ﬁnd that these LVOT-associated NOTCH1 alleles can
contribute to defective EMT in endothelial cell lines through impaired induction of Snail and Hes family
members. These data represent the ﬁrst description of a molecular mechanism underlying NOTCH1mutations
in individuals with LVOT malformations, and have important implications regarding the functional
contribution of these alleles to a complex set of developmental defects.+1 614 292 4466.
l rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Defects involving the left ventricular outﬂow tract (LVOT)
comprise a clinically signiﬁcant group of congenital cardiovascular
malformations. LVOT malformations, including bicuspid aortic valve
(BAV), aortic valve stenosis (AVS), coarctation of the aorta (COA), and
hypoplastic left heart syndrome (HLHS), are present in 1 in 1000 live
births, and account for a signiﬁcant portion of infant mortality [1–3].
Although the etiology of LVOT malformations is unclear, both
environmental and genetic components play a role in disease
pathogenesis. For example, prenatal exposure to solvents or high
phenylalanine levels (secondary to maternal phenylketonuria) have
been associated with higher incidence of LVOT malformations [4]. In
addition, linkage analysis demonstrates a strong genetic component
for these malformations. A non-parametric linkage analysis of LVOT
malformation shows linkage to three chromosomes with overlapping
linkage peaks suggesting a common genetic cause [5]. Mutations in
NOTCH1 have been reported in two families with bicuspid aortic valve
(BAV) and calciﬁc AVS [6], in sporadic BAV [7,8], and by our group inBAV, AVS, COA, and HLHS [9]. In support of the presumed common
genetic pathogenic mechanism, we identiﬁed NOTCH1 missense
variants in patients across the LVOT phenotypic spectrum and found
that these alleles reduce ligand-dependent Notch signaling [9].
Notch signaling is an evolutionarily conserved pathway that
regulates cell fates and tissue formation during embryogenesis,
including cardiac development [10,11]. The NOTCH1 receptor is
synthesized as a large polypeptide with 36 EGF-like repeats in the
extracellular domain, three NOTCH/Lin repeats, a transmembrane
domain, a transactivating domain, and intracellular domain with six
ankyrin repeats to facilitate protein–protein interactions. Mammalian
NOTCH1 is synthesized as a single 300-kDa polypeptide in the
endoplasmic reticulum (ER) and cleaved by a furin convertase during
posttranslational processing in the Golgi complex into p120 and p180
(S1 cleavage, see Fig. 1A). Following cleavage, the two portions of the
protein are presented as a functional heterodimer on the cell surface.
Ligands of the Delta and Jagged families presented on adjacent cells
can interact with the extracellular domain of NOTCH1. This interaction
triggers two subsequent cleavages (S2 and S3), resulting in the release
of the intracellular domain (NICD). NICD translocates into the nucleus,
where it functions in the activation of downstream targets including
members of the Hairy-Enhancer of Split (Hes) family of transcription
factors [12].
Fig. 1. Reduced S1-cleavage of NOTCH1A683T receptor. A. Schematic showing the
expected NOTCH1 products after typical processing events. The full length NOTCH1
protein (300 kDa) is cleaved at site 1 (S1) before presentation at the plasma membrane
as a functional heterodimer (p180 and p120). Interaction with ligand triggers two
subsequent cleavages (S2 and S3), releasing the intracellular domain (NICD) to activate
downstream transcription factors. The LVOT-associated mutations (G661S, A683T) are
located in the seventeenth and eighteenth EGF repeats in the extracellular domain (EC).
B. Total protein lysates from three independent NIH3T3 cell lines stably expressing
either N-terminally HA-tagged wild-type rNOTCH1 (clones C, H, I), rNOTCH1G661S
(clones E, L, M), or NOTCH1A683T (clones A, H, R) receptor were analyzed bywestern blot
using an anti-HA antibody. Note the decreased levels of the 180 kDa band (S1 Processed)
in cells expressing the rNOTCH1A683T receptor compared with wild-type rNOTCH1-
expressing cells. Results from a representative experiment are shown. C. Band
intensities were quantiﬁed and the percentage of total receptor that has undergone
S1 cleavage was calculated (180 kDa/180+300 kDa). The average ratio of S1-cleaved
protein is shown as the mean±SD from three independent experiments. p-values were
calculated using ANOVA followed by Bonferroni post hoc.
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signaling during cardiac development. In themouse, targeted deletion
of Notch1 or its nuclear partner RBPJK/CBF1/Su(H) results in impaired
epithelial-to-mesenchymal transition (EMT) during cardiac cushion
development, leading to a collapsed endocardium and the absence of
cushion cells in the mesenchyme [13]. Combined loss of Notch1
downstream targets, Hey1 and HeyL also causes impaired EMT in mice
[14]. EMT occurs in the endocardium around E9.0 to form the cardiac
cushions, and is critical for proper outﬂow tract and atrioventricular
canal development. During cardiac EMT, endocardial cells undergo
signiﬁcant changes in gene expression including Notch1-dependent
induction ofα-SMA, Snail1, and Snail2 [15,16]. In addition to its role in
EMT, recent data indicates that Notch signaling plays additionalcritical roles in both the neural crest and the secondary heart ﬁeld
during development [17,18].
In this study we examine the impact of LVOT-associated NOTCH1
mutations on Notch processing and induction of EMT. Two previously
identiﬁed missense NOTCH1 variants that reduce JAGGED1 depen-
dent Notch signaling are observed across a wide spectrum of LVOT
phenotypes. One variant (NOTCH1G661S) was present in patients with
AVS, CoA, and HLHS, as well as in a patient with bicuspid aortic valve
(BAV), reinforcing the idea of a common pathogenic mechanism.
Interestingly, although these mutations are found at highly conserved
sites within the NOTCH1 protein, alignment with other EGF repeats
suggests that they might be well-tolerated substitutions. Indeed, all
of these variants were also observed in an unaffected parent, so they
can be tolerated in some developmental conditions. Given these
conﬂicting ﬁndings, we examined the functional effects of these
mutations on NOTCH1 protein maturation, trafﬁcking and function,
as well as their effects on the induction of EMT in endothelial cell
lines, to determine how these missense variants might contribute to
human disease.2. Materials and methods
2.1. Cell culture and plasmids
NIH3T3 cells were cultured as previously described [9]. The HMEC-
1 microvascular endothelial cell line was provided by the Centers for
Disease Control and Prevention (Atlanta, Ga) and cultured as
previously described [19]. Rat cDNAs encoding N-terminally HA-
tagged rat NOTCH1, mutant NOTCH1G661S, and mutant NOTCH1A683T
were described previously [9]. GenBank Accession numbers are
NM_017617.3 for human NOTCH1 and NM_001105721.1 for rat
NOTCH1. Protein numbering reﬂects the initiation codon as codon 1.
To generate stable NOTCH1 cell lines, 4×104 NIH3T3 cells were plated
in 24well plates and transfected using Lipofectamine 2000with 0.8 μg
HA-tagged wild-type or mutant NOTCH1 expression vectors. Stable
lines were generated by expanding individual colonies after culturing
the cells for 15 days after transfection in the presence of G418
(0.6 mg/ml). NOTCH1 expression levels were determined by western
blot. Cell lines exhibiting a range of NOTCH1 expression levels were
expanded for use in further studies. Cell lines exhibiting similar levels
of wild-type or mutant NOTCH1 were maintained to facilitate
comparison between cell lines.2.2. Western blot
1.5×105 NIH3T3 cells stably expressing NOTCH1, mutant
NOTCH1G661S, or mutant NOTCH1A683T were plated in 6 well plates.
After 24 h cells were lysed, run on a 6% SDS-PAGE gel, transferred to
nitrocellulose, and NOTCH1 protein was detected with a mouse anti-
HA antibody (HA-7, 1:1000, Sigma-Aldrich) and Alexaﬂuor anti-
mouse 688 secondary antibody (1:20,000, Invitrogen). Band intensity
was quantiﬁed using Li-Cor Odyssey 2.1 software. All exposures were
in the linear range, as determined by this software. p300 and p180
bands were quantiﬁed, and the % of total protein cleaved was
calculated as p180/(p180+p300). Each experimentwas performed in
triplicate and statistical analysis was performed (one way ANOVA,
followed by Bonferroni post hoc). Western blots after co-culture
assays were performed essentially as above, using the following
primary antibodies: SNAIL 1(Cell Signaling Technologies #3895
1:1000), SNAIL 2 (Cell Signaling Technologies #9585 1:500), Hey2
(Millipore #AB15632 1:1000), HEYL (Millipore #MAB10094, 1:1000)
and α-Tubulin (Sigma-Aldrich T5168 1:1000). In some cases, western
blots were developed using ECL plus, following the manufacturers
recommendations.
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1.5×105 NIH3T3 cells stably expressing NOTCH1, mutant
NOTCH1G661S, or mutant NOTCH1A683T were plated in 6 well plates.
After 24 h, cells were incubated with 0.5 mg/ml sulfo-NHS-biotin
(Pierce) for 2 h at 4 °C. After washing, cell lysates were prepared in
RIPA buffer. Ten percent of each sample (35 μl)was removed and stored
at −80 °C. The remaining lysate (315 μl) was incubated with 40 μl of
streptavidin agarose resin (Thermo Scientiﬁc) overnight at 4 °C. Avidin-
bound biotinylated samples (50 μl) and their respective total lysates
(35 μl) were analyzed by western blot as described above. The amount
of NOTCH1 at the cell surface was quantiﬁed as biotinylated receptor
(B)/total amount of expressed receptor (T) and expressed as the relative
ratio of biotinylated NOTCH1. Each experiment was performed in
triplicate and statistical analysis was performed (one way ANOVA,
followed by Bonferroni post hoc).
2.4. Immunoﬂuorescent protein localization
2×104 NIH 3 T3 cells stably expressing NOTCH1, mutant
NOTCH1G661S, or mutant NOTCH1A683T were plated on acid treated
coverslips in 24 well plates. The following primary antibodies were
used: mouse (m) α-HA (1:1000, Sigma), rabbit (Rb) α-HA (1:1500,
Abcam),Rbα-EEA1 (1:500, Abcam),Rbα-Rab7 (1:100, Cell Signaling), r
α-calnexin (1:500, Abcam), m α-GM130 (1:100), and m α-smooth
muscle actin (1:200, Sigma). Alexa secondary antibodies (Molecular
Probes) were used at a dilution 1:1000: goat (gt)α-m 488 and gt α-Rb
594. For quantiﬁcation, 100 cells were counted for each experiment on
each cell line, and three independent experiments were performed. The
samples were blinded before quantiﬁcation.
2.5. EMT induction by co-culture
2×105 HMEC-1 cells were plated in a 6-well dish and transfected
24 h later using Lipofectin (Invitrogen) with 2 μg of NOTCH1, mutant
NOTCH1G661S, ormutant NOTCH1A683T expression vectors. In a separate
6-well plate, 2×105HMEC-1 cellswere transfectedwith2 μgof pEF-BOS
(vector), or pBOS-JAG1. 12 h post-transfection, HMEC-vector or HMEC-
JAG1 was co-cultured with HMECs expressing wild-type or mutant
NOTCH1 for 24 h. Total RNA was isolated for RT-PCR. Alternatively,
2×104 HMEC-1 cells were plated on coverslips and transfected 24 h
later using Lipofectin (Invitrogen) with 1 μg of NOTCH1, mutant
NOTCH1G661S, or mutant NOTCH1A683T expression vectors. After co-
culturewith controlHMEC-1 r JAG1-expressingHMEC-1 cells, cellswere
examined by immunoﬂuorescence.
3. Results
3.1. S1-cleavage of the NOTCH1A683T receptor is reduced
The NOTCH1G661S and NOTCH1A683T variants cause impaired
ligand-dependent Notch1 activation and are associated with LVOT
malformations [9].To determine the molecular cause of the impaired
signaling, we examined whether these mutations affect NOTCH1
receptor processing. The NOTCH1 receptor is synthesized as a single
300-kDa polypeptide in the endoplasmic reticulum and cleaved (S1)
by a furin convertase during posttranslational processing in the Golgi
complex into p120 and p180 before its presentation at the cell surface.
S1 cleavage has generally been believed to be required for CBF1
dependent Notch signaling, although more recent data suggests that
there is not an absolute requirement for S1 cleavage in NOTCH1
[20,21]. The reduction in ligand-induced signalingwhen S1 cleavage is
inhibited suggests that variants that reduce cleavage may exhibit
reduced ligand-dependent signaling. S1 cleavage analysis in NIH3T3
cells transiently overexpressing wild-type or variant NOTCH1 sug-
gested that S1 cleavage was reduced in NOTCH1A683T [9]. However,the high protein expression levels found in transient transfection can
impair protein processing and trafﬁcking, thus we conﬁrmed and
extended these observations in cell lines stably expressing varying
amounts of NOTCH1 protein. Independent, stable cell lines were
produced expressing NOTCH1WT, NOTCH1G661S or NOTCH1A683T.
Western blot analysis was used to select independent cell lines
expressing varying amounts of NOTCH1 receptor to control for effects
of protein expression levels.
Western blot analysis of cell lines stably expressing wild-type or
variant (G661S, A683T) NOTCH1 reveals the presence of full length,
unprocessed NOTCH1 as a band of 300 kDa and S1 processed NOTCH1
as a band of 180 kDa in all cell lines (Fig. 1B). As suggested by previous
work, we found that S1-processing is consistently reduced for
NOTCH1A683T; the ratio of total protein processed (p180/(p180+
p300)) averaged .66±.1 for the three wild-type NOTCH1 lines, but
only .29±.03 (pb .01) for the NOTCH1 A683T cell lines. In contrast, the
ratio of total processed protein averaged .52±.03 for the NOTCH1G661S
cell lines, indicating a slight but statistically insigniﬁcant reduction in S1
processing compared to wild-type (Fig. 1B,C). These data conﬁrm and
extend our previous ﬁndings, conﬁrming that alterations in
NOTCH1A683T S1-processing are a result of the missense mutation and
are not caused by protein overexpression.
3.2. Cell surface presentation of NOTCH1G661S and NOTCH1A683T
is reduced
Given the decrease in ligand-induced signaling of NOTCH1G661S
and NOTCH1A683T mutants [9], and the reduction of S1-cleaved
NOTCH1A683T, the amount of mutant receptor present at the plasma
membrane may be altered compared to wild-type. To address this
hypothesis, we performed cell-surface biotinylation experiments to
directly assess receptor presentation on the cell surface. In cell lines
stably expressing wild-type NOTCH1 receptor, the majority of
biotinylated receptors corresponded to the 180 kDa form (Fig. 2A),
indicating that under our conditions only the S1 cleaved form
efﬁciently reaches the cell surface. Likewise, the majority of
biotinylated NOTCH1G661S and NOTCH1A683T receptors corresponded
to the 180 kDa form with signiﬁcant amounts of p300 at the cell
surface seen in only one NOTCH1A683T line (Fig. 2A). Interestingly, the
relative amounts of receptor on the cell surface were signiﬁcantly
reduced in NOTCH1G661S and NOTCH1A683T cell lines compared to
lines expressing wild-type receptor. The relative ratio of biotinylated
receptor (expressed on the cell surface) to total amount of receptor
protein was 1.05±.04 for the three wild-type lines, whereas it was
0.38±.1 (pb .01) for NOTCH1G661S and 0.17±.03 (pb .01) for
NOTCH1A683T expressing cell lines (Fig. 2A,B). Thus, NOTCH1
receptors with mutations at either G661 or A683 are found at reduced
levels on the cell surface compared to wild-type receptors. In the
NOTCH1A683T mutation, this reduced cell-surface presentationmay be
a secondary effect of reduced S1 cleavage. Further, since S1 cleavage of
NOTCH1G661S appears to be normal in our analyses, the molecular
mechanism underlying the reduced cell-surface expression may be
distinct for each variant.
3.3. NOTCH1A683T receptor protein accumulates in the
endoplasmic reticulum
The decrease in S1 cleavage and the reduced levels of NOTCH1A683T
present at the cell surface compared to wild-type could both result
from impaired intracellular trafﬁcking. For instance, it is possible that
the observed reduction in S1 cleavage of NOTCH1A683T could be a
consequence of either impaired S1 cleavage in the Golgi, or of reduced
transport of the receptor from the endoplasmic reticulum (ER) to the
Golgi. To test these hypotheses, we analyzed NOTCH1 intracellular
localization by immunoﬂuorescence in cells stably expressing wild-
type or mutant receptors. In most cells expressing wild-type NOTCH1,
Fig. 2. Reduced amounts of NOTCH1G661S and NOTCH1A683T are presented at the plasma membrane. A. Proteins expressed on the plasma membrane of NIH3T3 stable cell lines
expressing either rNOTCH1WT, rNOTCH1G661S, or rNOTCH1A683T receptor were labeled by biotinylation. Ten percent of the total protein extract was removed (T) after which
the remaining lysate was subjected to streptavidin pull down (B), to isolate cell-surface proteins. Western blot analysis of total protein lysate (T) and cell-surface proteins
(B) was performed using an anti-HA antibody. The 180 kDa band present in all biotinylated fractions indicates that only the S1 cleaved form of rNOTCH1 reaches the plasma
membrane efﬁciently. Note the relative decrease in biotinylated receptor in cell lines expressing rNOTCH1G661S or rNOTCH1A683T mutants compared to cell lines expressing
wild-type NOTCH1. anti-GM130 antibody was utilized to assess fraction purity. Representative data are shown. B. Band intensities were quantiﬁed and the ratio of biotinylated
NOTCH1 to total NOTCH1 was calculated. Results are graphed as mean±SD from three independent experiments. p-values were calculated using ANOVA followed by
Bonferroini post hoc.
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structures, and present at the cell surface, similar to previous
descriptions [22]. Similar localization was observed in cell lines
expressing NOTCH1G661S. In contrast, the majority of cells expressing
the variant NOTCH1A683T receptor exhibited protein localization in the
perinuclear region with a corresponding reduction in protein at the
cell surface and in vesicle-like bodies. To quantify the mislocalization
of NOTCH1A683T, 100 cells from each cell line were counted, and
classiﬁed as having protein largely in perinuclear regions (see, for
example Fig. 3A. panels i, l) or having protein throughout the cell
(Fig. 3A, panels a and j). Three independent experiments were
performed for each cell line, demonstrating a signiﬁcant increase in
the number of cells with perinuclear protein staining for cells
expressing NOTCH1A683T compared to cells expressing NOTCH1G661S
or wild-type NOTCH1 (Fig. 3B).
To further deﬁne the intracellular localization of the variant
NOTCH1A683T protein, we performed immunoﬂuorescence with
markers for Golgi (GM130), ER (Calnexin), early endosome (EEA1),
and late endosome (Rab7). In the majority (73%) of cells expressingNOTCH1A683T, mutant protein co-localized with an ER marker,
calnexin (Fig. 3A: f”; B), whereas only 20% of cells expressing wild-
type NOTCH1 exhibited co-localization with calnexin (Fig. 3A: d”; B).
These ﬁndings indicate that trafﬁcking of the mutant NOTCH1A683T
receptor from the ER to the Golgi is impaired, leading to less protein
present in the Golgi for S1 cleavage, and ultimately less protein
presented at the cell surface. This suggests that the A683T mutation
may impair proper protein folding, leading to the retention of the
protein in the ER.
In contrast to our ﬁndings for NOTCH1A683T protein, the localiza-
tion pattern in the majority (68%) of cells expressing mutant
NOTCH1G661S was similar to that seen in wild-type cells, although
the cell-surface expressionwas sometimes reduced (Fig. 3A: compare,
for example, panel a with panel b), consistent with the biotinylation
data reported above. We did not observe co-localization with
Golgi markers in wild-type NOTCH1, NOTCH1G661S, or NOTCHA683T
(Fig. 3A:a–c), reﬂecting that NOTCH1 protein is only transiently
present in the Golgi. Both wild-type NOTCH1 and NOTCH1G661S
exhibited some co-localization with EEA1 and Rab7, although no
Fig. 3. The LVOT-associated mutant NOTCH1A683T exhibits improper intracellular
trafﬁcking and localization to the endoplasmic reticulum (ER). A. The subcellular
location of rNOTCH1 receptors in stable NIH 3T3 cells was assayed by immunoﬂu-
orescence. Costaining of NOTCH1 with the Golgi-marker GM130 (a–c) did not reveal
co-localization in cells expressing rNOTCH1WT (a–a”), rNOTCH1G661S (b–b”), or
rNOTCH1A683T (c–c”). Costaining of Notch1 with ER-marker calnexin (d–f) revealed
strong co-localization of the mutant rNOTCH1A683T protein with calnexin in the
majority of cells observed. Costaining of NOTCH1 with early endosome marker EEA1
(g–i) revealed some co-localization although no signiﬁcant differences were
observed. Similarly, some co-localization with late endosome marker Rab7 was
observed, although the degree of co-localization was similar among all cell lines (j–l).
Scale bars are 10 μm. B. Two stable lines expressingwild-type ormutant NOTCH1were
co-stained for ER-marker calnexin and NOTCH1 (anti-HA) as above. The co-
localization of NOTCH1 and calnexin was assessed in 100 cells, and the percent of
cells exhibiting NOTCH1 localization in the ER is shown. In cells expressing
rNOTCH1A683T, co-staining reveals a signiﬁcant increase in localization of mutant
protein to the ER (pb .001). In addition, ER localization is slightly lower in cell lineWT
H compared to lines expressing NOTCH1G661S (pb .05). % ER localization is calculated
from three independent experiments. Values were analyzed by ANOVA followed by
Bonferroni post hoc.
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endocytic processing of the mutant NOTCH1G661S receptor is not
demonstrably different than that of wild-type NOTCH1 receptor.
These ﬁndings reinforce the suggestion that distinct mechanisms
underlie the reduction in ligand-induced Notch signaling observed in
the NOTCH1A683T and the NOTCH1G661S variants.
3.4. NOTCH1G661S and NOTCH1A683T mutations cause reduced expression
of Notch-responsive EMT markers
These ﬁndings, together with our previous report [9] demonstrate
that the A683T and G661S variants in NOTCH1 variably affect protein
folding, processing and cell-surface presentation, resulting in a partial
loss of ligand-induced Notch signaling. It remains to be demonstrated
that this reduction in signaling has an overt effect on developmental
processes that require Notch function. To address this question, we
examined the effect of missense variants in the NOTCH1 receptor on
the pathway's function in EMT. During cardiac EMT, endocardial cells
that overlie the atrioventricular (AV) canal and outﬂow tract lose
apical–basal polarity, invade the cardiac jelly, and form the endocar-
dial cushions. EMT in the outﬂow tract is an essential process for
proper development of the aortic valve [23]. Recent work has shown
that Snail2 is directly upregulated by Notch in endothelial cells and
that expression of both Snail1 and Snail2 is required for cardiac
cushion EMT in vivo [15].
To examine the effects of LVOT-associated NOTCH1 variants on
EMT we took advantage of the recent ﬁnding that co-culture of
HMEC-1 cells (an immortalized human microvascular endothelial
cell line) with HMEC-1 cells expressing JAGGED1 can induce EMT in
signal-receiving cells, as demonstrated by induction of α-SMA, a
direct Notch target [24] and phenotypic changes indicative of
mesenchymal transition [16]. We utilized western blot analysis to
examine the relative expression of SNAIL1 and SNAIL2 after HMEC
cells expressing NOTCH1WT or variant NOTCH1 (NOTCH1G661S,
NOTCH1A683T) were co-cultured with HMEC cells expressing
JAGGED1. A robust induction of SNAIL1 and SNAIL2 was observed
when HMECs expressing wild-type NOTCH1 were co-cultured with
HMEC-JAGGED1 cells (Fig. 4A). In contrast, when HMEC cells
expressing either variant receptor were co-cultured with HMEC-
JAGGED1, we observed reduced SNAIL1 induction (69% reduction for
NOTCH1G661S and 58% reduction for NOTCH1A683T) compared to that
seen in NOTCH1WT co-cultured with HMEC-JAGGED1. Both variants
also exhibit signiﬁcant reductions in JAGGED1-dependent induction
of SNAIL2 (77% reduction for NOTCH1G661S and 55 % reduction for
NOTCH1A683T) (Fig. 4B). In addition, HEYL and HEY2 represent direct
Notch targets that play important roles in cardiac EMT [14]. As
observed for SNAIL1 and SNAIL2, we ﬁnd that JAGGED1-responsive
induction of both HEYL and HEY2 during EMT is signiﬁcantly
reduced in cells expressing either NOTCH1G661S or NOTCH1A683T
compared to cells expressing wild-type NOTCH1 (Fig. 4). These data
indicate that two LVOT-associated missense alleles, NOTCH1G661S
and NOTCH1A683T, have an impaired ability to induce the expression
of Notch-responsive markers of EMT.
3.5. NOTCH1G661S and NOTCH1A683T mutants exhibit impaired induction
of EMT
In order to determinewhether a partial reduction in Notch signaling
can affect the efﬁciency of the cellular transition of endothelial to
mesenchymal cell types, we performed co-culture assays as described
above followed by phase-contrast microscopy and immunoﬂuores-
cence. Epithelial cells appear as a unicellular layer, with uniformly
spaced cell–cell junctions and apical–basal polarity. In contrast,
mesenchymal cells exhibit a lack of intracellular adhesion, with
irregularly shaped, elongated cells. Mesenchymal cells also exhibit a
distinct leading edge polarity indicative of their dynamic migratory
Fig. 4. Reduced JAGGED1 dependent Notch1 activation of SNAIL1 and SNAIL2 in LVOT-associatedmutants. A. HMECs expressingWT or mutant rNOTCH1were co-cultured with HMEC
cells transfectedwith a control vector (HMEC-ctr) or a JAGGED1 expression vector (JAG1) for 24 h.Western blot analysis was performed using antibodies speciﬁc for SNAIL1, SNAIL2,
HEY2, HEYL, or Tubulin. Representative results are shown indicating that these markers are upregulated when signal-receiving cells expressing wild-type NOTCH1 receptor are co-
cultured with cells expressing JAGGED1, while activation of expression is reduced when signal-receiving cells express NOTCH1A683T or NOTCH1G661S. B. The induction of, SNAIL1,
SNAIL2, HEYL and HEY2 by JAGGED1 was compared in HMEC cells expressing wild-type NOTCH1, NOTCH1G661S or NOTCH1A683T. Band intensities were quantiﬁed and normalized to
the value for tubulin. Fold activation by JAGGED-expressing cells was calculated (level when co-cultured with JAGGED1 expressing cells/level when co-cultured with HMEC control
cells), and the value for fold activation in cells expressing wild-type NOTCH1 was set to one for comparison across experiments (actual fold increases were 6.1±1.2 for SNAIL1 and
8.0±4.3 for SNAIL2, 3.2±1.1 for HEYL, and 2.5±1.2 for HEY2). We observe an overall 50–80% reduction in the expression levels of SNAIL1, SNAIL2, HEYL and HEY2 in cells
expressing missense variants of NOTCH1 compared to cells expressing wild-type NOTCH1. Each experiment was performed at least three times in duplicate, and statistical analysis
was performed (**=pb .01, *=pb .05 by ANOVA, Dunnett post hoc).
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for wild-type ormutant NOTCH1, alongwith a GFP expression vector to
mark transfected cells. Co-culture of HMECs expressing exogenous
NOTCH1 receptor with Jagged1-expressing cells caused morphological
changes in some signal-receiving cells consistent with EMT (Fig. 5A). To
examine the relative efﬁciency of EMT in cells expressing wild-type
NOTCH1 compared to cells expressing missense variants of NOTCH1,
cells were stained with an anti-α-SMA antibody and examined by
immunoﬂuorescence. α-SMA expression and cell morphology were
observed in GFP positive signal-receiving cells (which are presumed to
express exogenouswild-type ormutant NOTCH1). Co-culture of HMECs
expressing wild-type NOTCH1 with JAGGED1-expressing cells induced
EMT in ~50% of GFP positive cells as determined by loss of apical–basal
polarity, loss of distinct intracellular junctions, and expression of EMT
marker, α-SMA (Fig. 5B,C). In contrast, co-culture of HMECs expressing
NOTCH1G661S or NOTCH1A683T variant receptors with JAGGED1-expres-
sing cells induced EMT in only 34% and 29% of GFP positive cells
respectively (Fig. 5B,C pb0.05). These results indicate that a partial
reduction in Notch1 signaling, which leads to reduced expression of
target genes can result in reduced efﬁciency of EMT in endothelial cells.4. Discussion
4.1. Distinct molecular mechanisms may underlie the reduction in
signaling through different mutant Notch1 receptors
We have previously reported that missense variants in the
human NOTCH1 gene identiﬁed in patients with LVOT defects are
correlated with a reduction in ligand-induced CBF1-dependent
Notch signaling [9]. Here we examine the molecular mechanism(s)
that contribute to this reduction in signaling. The examined variants
(NOTCH1G661S and NOTCH1A683T) are found in neighboring EGF
repeats (repeats 17 and 18), but our ﬁndings indicate that the
underlying molecular cause of the reduction in signaling of these
mutant receptors may be distinct.
We ﬁnd that NOTCH1A683T receptors exhibit both reduced S1
cleavage and a reduction in the amount of receptor found at the cell
surface (Figs. 1 and 2). Our data further indicate that mutant
NOTCH1A683T localizes to the ER in themajority of cells, in contrast to
the usual NOTCH1 protein localization in small vesicle-like bodies,
and at the cell surface. These data may indicate that the A683T
Fig. 5. Cell lines expressing LVOT-associated NOTCH1 variants exhibit defective
JAGGED1-induced EMT. A. Phase-contrast micrographs of HMECs expressing wild-
type NOTCH1 co-cultured with HMEC cells containing empty vector (a) or JAGGED1
expression vector (b). When NOTCH1 expressing cells are co-cultured with JAGGED1
expressing cells, they undergo a morphological transformation characterized by loss
of intercellular junctions, loss of cellular monolayer, formation of ﬁlopodia, and
irregular cell shape (arrows). B. HMECs co-transfected with a NOTCH1 expression
vector and a GFP expression vector were co-cultured with control HMECs (a and b) or
HMECs expressing JAGGED1 (c and d). Transfected cells (as identiﬁed by GFP
expression (a, c)) were examined for α-SMA staining (b and d). Cells underwent EMT
only when NOTCH1 expressing HMECs were co-cultured with HMECs expressing
JAGGED1 (compare arrows in b to arrowheads in d). C. The efﬁciency of EMT
induction by JAGGED1 was compared between cells expressing wild-type NOTCH1
and cells expressing NOTCH1G661S or NOTCH1A683T. The percentage of transfected
cells (as identiﬁed by GFP expression) that had also undergone EMT (as deﬁned by
morphology and α-SMA expression) was quantiﬁed. The percentages reﬂect the
average efﬁciency of EMT for100 observed cells in three independent experiments.
The efﬁciency of EMT is signiﬁcantly reduced in cells that express mutant forms of the
NOTCH1 receptor (pb0.05, ANOVA followed by Dunnet post hoc).
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hydrophilic polar amino acid, interferes with proper protein folding,
resulting in the retention of the misfolded protein in the ER. This
retention, and the presumed subsequent degradation of misfolded
protein would result in a reduced S1 cleavage, reduced cell-surface
presentation, and a subsequent reduction in ligand-induced signal-
ing. There exists some precedent that missense mutations in EGF
repeats can cause protein misfolding. For instance, the G274S
mutation in JAGGED1 identiﬁed in patients with tetralogy of Fallot
impairs folding of the EGF repeat [25]. It may also be interesting to
note that EGF repeat 18 is a reported substrate for fucosylation bythe enzyme POFUT1 [26]. In Drosophila, Ofut1 protein possesses
an essential, chaperone function that is required for stable, cell-
surface expression of NOTCH [27]. In contrast, however, in mamma-
lian cells POFUT1 is not required for cell-surface expression, although
fucosylation of Notch receptors is required for optimal ligand
binding [28].
In contrast to our ﬁndings for NOTCH1A683T, we ﬁnd that the
NOTCH1G661S variant does not overtly affect either folding or S1
processing. However, like NOTCH1A683T, NOTCH1G661S is found at
reduced amounts at the cell surface (Figs. 1 and 2). We presume that
the reduced amount of receptor at the cell surface contributes to the
observed reduction in ligand-induced signaling, but the mechanisms
for this change in protein trafﬁcking are not clear. G661 is found in
EGF repeat 17, which has been reported to be modiﬁed by addition of
an O-linked glucose [26]. In Drosophila, loss of the enzyme that
catalyzes this modiﬁcation causes a temperature sensitive Notch
phenotype, and accumulation of the receptor on the cell surface [29].
The functions of EGF glucosylation in mammalian cells are poorly
understood [30]. It is also possible that this amino acid change
interferes with other modiﬁcations of the receptor during intracel-
lular processing. For instance, in mammalian cells, the E3 ubiquitin
ligases Cbl and Itch/AIP4 have been shown to modify Notch but the
biological importance of these alterations are currently not known
[31,32]. Some studies have shown that NOTCH1 cell-surface
expression is negatively regulated by the addition of ubiquitin
signals during intracellular trafﬁcking [33,34]. Since ubiquitination is
often linked to the endocytic pathway, it is possible that improper
modiﬁcations to the mutant receptor lead to alterations in endocytic
trafﬁcking that are not noticeable by immunoﬂuorescence, butwhich
nonetheless affect receptor presentation at the cell surface. These
results suggest that diverse molecular mechanisms can perturb
Notch1 signaling during cardiac development.4.2. Reductions in ligand-induced Notch signaling can affect cell fate
during EMT
The NOTCH1 variants identiﬁed in patients with LVOT malforma-
tions are predicted to reduce, but not abolish, Notch signaling. This
implies that at least some of the processes during cardiac develop-
ment that require Notch signaling will have dosage sensitive
outcomes. We examined the function of the NOTCH1A683T and
NOTCH1G661S variants during JAGGED1-induced EMT to determine
whether the partial reductions we described in Notch signaling could
inﬂuence cell fate decisions. EMT in the outﬂow tract cushions is
necessary for proper formation of the aortic and pulmonary valves. In
response to signals from the adjacent myocardium, the endocardium
undergoes Notch-dependent EMT via upregulation of the Snail family
of transcription factors [13,16,35,36]. Mice with loss-of-function
mutations in the Notch pathway display collapsed endocardium,
lack mesenchymal cushion cells, and exhibit defective invasion of
endocardial cells into the cardiac jelly, indicative of impaired EMT in
the outﬂow tract [13,14]. We ﬁnd that endothelial cells that express
mutant forms of the NOTCH1 receptor protein exhibit reduced
JAGGED1-dependent expression of critical EMT inducers Snail1,
Snail2, and α-SMA, as well as reduced expression of the canonical
Notch targets HEY2 and HEYL (Fig. 4). This reduction in the
expression levels of critical mediators of EMT leads to an actual
reduced efﬁciency in JAGGED1-induced EMT compared to cells
expressing wild-type NOTCH1 receptors (Fig. 5). Thus our data
support the hypothesis that relatively small reductions in NOTCH1
signaling can adversely affect key processes in cardiac development.
These ﬁndings support the proposal that reduced Notch signaling
and the resulting reduction in the efﬁciency of EMT could serve as a
unifying event whereby Notch mutations contribute to diverse LVOT
malformations.
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tract development
Although impaired EMT in the outﬂow tract may provide a
unifying pathogenesis for diverse LVOT malformations, there are
several additional cardiac developmental processes that may be
sensitive to reductions in Notch1 signaling. Dosage sensitivity in any
of these developmental decisions could also contribute to cardiac
defects in patients carrying Notch1 variant proteins. The outﬂow tract
is generated by interactions among many different cell types,
including cardiomyocytes, neural crest derived cells, the secondary
heart ﬁeld, and endothelial cells. Neural crest derived cells give rise to
the smooth muscle layer of the aorta and pulmonary artery and
contribute to the semilunar valve leaﬂets. Notch signaling is essential
for the differentiation of cardiac neural crest progenitors into smooth
muscle cells in vivo, as blocking Notch signaling in the derivatives of
the cardiac neural crest results in stenosis of the vessels and aortic
arch defects resembling that seen in Alagille syndrome [17]. The
smooth muscle layer is believed to be critical for maintaining the
structure of the arteries, indicating that defects in Notch signaling
resulting from LVOT-associated NOTCH1 alleles in neural crest derived
cells could contribute to CoA, which results from a narrowing of the
aorta. In addition, recent work has demonstrated that altering Notch
signaling levels in cardiomyocytes can result in cardiac defects [37].
Notch signaling in the second heart ﬁeld is also important for
proper outﬂow tract development. The second heart ﬁeld is a group of
mesoderm derived cells that migrate from the anterior pharynx into
the heart and gives rise to the myocardium of the outﬂow tract, right
ventricle, interventricular septum, part of the atria, and smooth
muscle at the bottom of the outﬂow vessels [38–43]. Recent work
demonstrates that JAGGED1-dependent Notch signaling in the second
heart ﬁeld regulates the migration of neighboring neural crest cells,
and EMT in the endocardial cushions [18]. Together, these data
indicate that Notch plays multiple roles in tissue–tissue interactions
during outﬂow tract development, representing additional mechan-
isms where reductions in Notch signaling could perturb outﬂow tract
development. It is not unreasonable to suggest that as we have seen
during EMT, reductions in Notch signaling due to missense mutations
such as G661S or A683T may affect the efﬁciency of other cell fate
decisions that are critical to outﬂow tract development.
4.4. Reductions in Notch signaling may sensitize outﬂow tract
development to other genetic and environmental insults
It is important to remember that the NOTCH1 variants identiﬁed in
patients with LVOT malformations are not sufﬁcient to cause cardiac
defects. In all cases, the identical variant was found in an unaffected
parent [9]. One attractive explanation for this ﬁnding would be that
these missense variants, which lead to reductions, but not loss, of
Notch signaling, act to sensitize outﬂow tract development to other
genetic or environmental insults. This hypothesis is especially
intriguing in light of the fact that cells expressing mutant NOTCH1
receptors exhibit a reduction in the efﬁciency of EMT, but not a block
to the process. In the context of embryonic development, this partial
reduction might lead to a developmental window during which other
genetic or environmental insults could synergize with the reduction
in EMT to perturb development of the outﬂow tract in some
individuals. In other cases, in the absence of additional perturbations,
the level of EMT driven by these mutant receptors might be sufﬁcient
to support normal cardiac development, explaining the presence of
unaffected carriers of the variants. Some precedent exists for this idea.
Snail2-deﬁcient mouse embryos exhibit defective EMT at E9.5, which
might be considered equivalent to the reductions in EMT efﬁciencywe
observe in endothelial cells expressing variant NOTCH1 receptors.
However, in Snail2 deﬁcient embryos, EMT recovers by E10.5 due to
an increase in Snail1 expression [15]. It is attractive to hypothesizethat this transient deﬁciency during early outﬂow tract development
could sensitize the tissue to other environmental or genetic insults.
The severity of these additional insults may determine whether a
speciﬁc NOTCH1 variant leads to a simple bicuspid aortic valve or
severe hypoplastic left heart syndrome. Intriguingly, recent ﬁndings
from the Stanley lab indicate that reductions in Notch signaling may
act stochastically, or in combination with genetic background to
produce phenotypic outcomes of varying severity. Speciﬁcally, they
ﬁnd that the combination of the Notch112f hypomorphic allele with a
Notch1 null allele produces embryos of the genotype Notch112f/−with
a wide variation in phenotype [44]. Similarly, individuals carrying a
single copy of a NOTCH1missensemutationmay be at heightened risk
for cardiac malformations, dependent on genetic background or
environmental effects.
This study elucidates themolecular mechanisms bywhichmissense
mutations in the NOTCH1 receptor can contribute to LVOT malforma-
tions. We ﬁnd that two LVOT-associated NOTCH1 alleles reduce Jagged-
1 dependent Notch1 signaling by altering protein folding and proces-
sing and/or protein trafﬁcking. Expression of variant NOTCH1 receptors
in endothelial cells results in defective EMT as well as reduced Notch-
dependent induction of Snail family genes. Given the results of our
study and recent work of others in the ﬁeld, we propose that slight
reductions in NOTCH1 dosage can affect proper induction of endocar-
dial EMT, and that this change predisposes patients to develop varying
malformations of the outﬂow tract when additional critical pathways
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